Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR0QS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,525
Award facts
- Contract value 100% obligated
- $27,524.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,524.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 300 milligram/2 milliliter Dupixent pens on January 29, 2026, with an ultimate completion date of January 30, 2026. This competitively awarded, non-set-aside contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems.
Dupixent is a specialty pharmaceutical product used to treat various allergic and inflammatory conditions, and this delivery order fulfills medical supply needs for military treatment facilities and defense health programs. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contracts with the Defense Logistics Agency, supplying a comprehensive range of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The parent IDC vehicle represents Cencora's strategic role in supporting global pharmaceutical supply chains for U.S. military healthcare operations and broader federal medical procurement initiatives.
Quick answers
Who was awarded contract SPE2DR26FR0QS?
SPE2DR26FR0QS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FR0QS worth?
The government has obligated $27,525 on SPE2DR26FR0QS.
Is contract SPE2DR26FR0QS an order under another contract?
Yes. SPE2DR26FR0QS is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0QS competed?
The extent of competition for SPE2DR26FR0QS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award